Korea Health Industry Development Institute (KHIDI), a government-affiliated institution of the international competitiveness in the health industry and Medetarian Conferences Organizing (MCO), the leading healthcare events management in the UAE have hosted the Current Clinical Oncology of Korea Webinar on Friday, October 30th, 2020 with 345 participants in the United Arab Emirates and across the world. Joining the virtual conference were Korean-based speakers specializing in the field of Pediatrics and Surgery.
Webinar Chairman Dr. Aladdin Maaraoui, Consultant and Chief of Hematology/Oncology and Clinical Professor at Gulf Medical University delivered his greetings and shared the flow of the 2-hour agenda filled with new insights in the current updates all related to Oncology.
In medical literature, Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. The name’s etymological origin is the Greek word ὄγκος (óngkos), meaning 1. “burden, volume, mass” and 2. “barb”, and the Greek word λόγος (logos), meaning “study”. (Wikipedia).
Highlighting the first topic on “Surgical Approach for Advanced HCC”, Dr. Gi-won SONG, MD, Ph.D., Professor (Department of Surgery) at Asan Medical Center has shared his exploration from the viewpoint of surgeons the definition of Advanced HCC. In his presentation, he otherwise acknowledged that the idea of surgery has been always associated with pain and risk factors. However, with the evolution in this particular field of study, a new approach called surgical resection has been known as the most reliable local treatment for HCC with verified efficacy and served as a “Gold Standard” treatment procedure. He also notes in conclusion that the treatment guideline for HCC is very limited but still considered valid during the desperate need of treatment.
Ji Won LEE, MD, Ph.D., Associate Professor (Department of Pediatrics) at Samsung Medical Center has exhibited a virtual discussion on the “Treatment of Solid Tumors in Children at Samsung Medical Center” in which she outlined the treatments for Pediatric Solid Tumors citing the conventional treatment: Surgery, Chemotherapy, and Radiotherapy. Samsung Medical Center as a whole specialized in the treatment of high-risk or recurrent tumors, particularly neuroblastoma and brain tumors. Ji Won LEE adds, “Our aim of treatment is both to improve survival rate and to reduce late adverse effects.”
The second to the last speaker on the virtual podium was Jae Wook LEE, MD, Ph.D., Associate Professor (Department of Pediatrics) at Seoul St. Mary’s Hospital on the topic of “Complications of Allogeneic Hematopoietic Stem Cell Transplantation”. In his presentation, he cited a case (out of eight) of a 10-year-old female patient diagnosed with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia and achieved complete remission (CR) with 4-drug remission induction chemotherapy. Supplementing his broad knowledge on the said treatment he notes, “For patients who show a significant amount of diarrhea after transplantation it is always necessary to differentiate between acute GVHD and CMV.”
Last but not the least, Byung Soh MIN, MD, Ph.D., Professor (Department of Surgery) at Yonsei University College of Medicine showcased his dialogue on the topic of “Severance Robot & MIS Center”. In an overview of Robotic Surgery he notes, “We have been the first and the best in the robotic surgery in Korea. We’ve performed the first two robotics surgery back in 2005 and established the first robotic training center in Korea.” This testimony alone coming from an expert is a testament that robotics surgery is a revolutionary approach in the name of medical examination.
At Severance Yonsei, Byung Soh MIN also provided further information about their state-of-art facilities that cater to all kinds of robotic surgeries.
This very interesting webinar is CME accredited. To view the full-length discussion on Current Clinical Oncology of Korea Webinar, watch the video here: https://www.youtube.com/watch?v=An0KslAbAfw